factmr

Goodpasture Syndrome Treatment Market: Introduction

The Goodpasture syndrome is a rare autoimmune and life-threatening disease. It affects both kidneys and lungs. The Goodpasture syndrome was first identified by Dr. Ernest Goodpasture in 1919. It is also known as anti-GBM disease. In goodpasture syndrome, antibodies are produced against a specific region of collagen in kidneys and lungs. The initial symptoms of goodpasture syndrome are fatigue, loss of appetite, vomiting, and pale appearance. Sometimes, the symptoms of goodpasture syndrome become life-threatening and cause respiratory failure, especially if there is a lot of bleeding. The Goodpasture syndrome majorly affects the kidney and causes a burning sensation during urination, swelling of hands and feet, back pain, elevated blood pressure readings and others. Goodpasture syndrome treatment involves medications which slow down the immune system.

The treatment depends on the age, overall health of an individual and severity of the disease. The diagnosis of goodpasture syndrome can be done through urinalysis, blood test, chest X-ray and biopsy. Presently, the exact cause of goodpasture syndrome is still not known. Goodpasture syndrome develops due to unknown causes. Cigarette smoke, hydrocarbon chemical exposure and infections, such as influenza, may be some of the causing factors. The goodpasture syndrome can become fatal if not diagnosed and treated on time. In severe cases, goodpasture syndrome treatment includes procedures where waste products are removed from the blood. In most severe cases, goodpasture syndrome treatment requires kidney transplantation. Goodpasture syndrome treatment reduces the severity of the symptoms. In addition, the treatment also prevents the destruction of lung tissues and kidney. 

You can Get Free Sample Report Here @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1503